| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,132 |
5,971 |
$382K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
480 |
368 |
$77K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
833 |
582 |
$56K |
| 99243 |
|
263 |
249 |
$30K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
147 |
113 |
$20K |
| 80061 |
Lipid panel |
1,809 |
1,420 |
$20K |
| 86769 |
|
719 |
302 |
$18K |
| Q3014 |
Telehealth originating site facility fee |
873 |
659 |
$13K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
76 |
68 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,105 |
898 |
$11K |
| 87486 |
|
488 |
373 |
$10K |
| 87581 |
|
494 |
372 |
$10K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
489 |
373 |
$10K |
| 93000 |
|
636 |
475 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
225 |
192 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,734 |
836 |
$8K |
| 94060 |
|
290 |
208 |
$7K |
| 94729 |
|
291 |
210 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
459 |
332 |
$6K |
| 94727 |
|
291 |
208 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
72 |
49 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
241 |
209 |
$4K |
| 82947 |
|
1,159 |
856 |
$3K |
| 94200 |
|
290 |
208 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
259 |
183 |
$3K |
| 90674 |
|
132 |
104 |
$2K |
| 95816 |
|
20 |
17 |
$2K |
| 81025 |
|
520 |
408 |
$1K |
| 95819 |
|
14 |
12 |
$1K |
| 95923 |
|
33 |
14 |
$962.00 |
| 94010 |
|
57 |
42 |
$936.00 |
| 93922 |
|
37 |
14 |
$760.00 |
| 72100 |
|
38 |
25 |
$630.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
38 |
36 |
$607.54 |
| 95921 |
|
31 |
13 |
$572.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
33 |
28 |
$525.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
136 |
105 |
$480.00 |
| 81002 |
|
178 |
122 |
$378.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
238 |
123 |
$229.34 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
23 |
12 |
$3.96 |
| 71020 |
|
21 |
15 |
$0.00 |